{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:51:50Z","timestamp":1780051910314,"version":"3.53.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T00:00:00Z","timestamp":1539302400000},"content-version":"am","delay-in-days":315,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI100890"],"award-info":[{"award-number":["AI100890"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007249","name":"Research Development and Seed Grant Program of the Center for Drug Design, University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. DOE","doi-asserted-by":"publisher","award":["DE-AC02-06CH11357"],"award-info":[{"award-number":["DE-AC02-06CH11357"]}],"id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.ejmech.2017.09.054","type":"journal-article","created":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T02:00:27Z","timestamp":1506564027000},"page":"149-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Design, synthesis and biological evaluations of N-Hydroxy thienopyrimidine-2,4-diones as inhibitors of HIV reverse transcriptase-associated RNase H"],"prefix":"10.1016","volume":"141","author":[{"given":"Jayakanth","family":"Kankanala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen A.","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary C.","family":"Casey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan G.","family":"Sarafianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1326-5986","authenticated-orcid":false,"given":"Zhengqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2017.09.054_bib1","unstructured":"https:\/\/www.aids.gov\/hiv-aids-basics\/hiv-aids-101\/global-statistics\/index.html."},{"key":"10.1016\/j.ejmech.2017.09.054_bib2","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1021\/jm801071m","article-title":"Derivatives of 5-nitro-furan-2-carboxylic acid carbamoylmethyl ester inhibit RNase H activity associated with HIV-1 reverse transcriptase","volume":"52","author":"Fuji","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.054_bib3","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1021\/jm900597q","article-title":"RNase H active site inhibitors of human immunodeficiency virus type 1 reverse transcriptase: design, biochemical activity, and structural information","volume":"52","author":"Kirschberg","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.054_bib4","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1039\/C4MB00147H","article-title":"\u201cOld dogs with new tricks\u201d: exploiting alternative mechanisms of action and new drug design strategies for clinically validated HIV targets","volume":"10","author":"Kang","year":"2014","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.ejmech.2017.09.054_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2009.09.014","article-title":"Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine","volume":"85","author":"Cihlar","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2017.09.054_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.antiviral.2009.09.008","article-title":"Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: a review of the last 20 years (1989-2009)","volume":"85","author":"de Bethune","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2017.09.054_bib7","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.2174\/138955708786141052","article-title":"Recent advances in the research of HIV-1 RNase H inhibitors","volume":"8","author":"Yu","year":"2008","journal-title":"Mini. Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.054_bib8","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.2174\/0929867321666140120121158","article-title":"Recent progress in the research of small molecule HIV-1 RNase H inhibitors","volume":"21","author":"Cao","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.054_bib9","article-title":"Update on recent developments in small molecular HIV-1 RNase H inhibitors (2013-2016): opportunities and challenges","volume":"24","author":"Wang","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.054_bib10","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1074\/jbc.C200621200","article-title":"Inhibition of HIV-1 ribonuclease H by a novel diketo acid, 4-5-(benzoylamino)thien-2-yl -2,4-dioxobutanoic acid","volume":"278","author":"Shaw-Reid","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2017.09.054_bib11","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1093\/nar\/gkg881","article-title":"Two-metal ion mechanism of RNA cleavage by HIV RNase H and mechanism-based design of selective HIV RNase H inhibitors","volume":"31","author":"Klumpp","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2017.09.054_bib12","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1021\/jm501132s","article-title":"Design, synthesis, biochemical, and antiviral evaluations of C6 benzyl and C6 biarylmethyl substituted 2-hydroxylisoquinoline-1,3-diones: dual inhibition against HIV reverse transcriptase-associated RNase H and polymerase with antiviral activities","volume":"58","author":"Vernekar","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.054_bib13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejmech.2017.03.059","article-title":"Synthesis, biological evaluation and molecular modeling of 2-Hydroxyisoquinoline-1,3-dione analogues as inhibitors of HIV reverse transcriptase associated ribonuclease H and polymerase","volume":"133","author":"Tang J","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.054_bib14","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.str.2009.09.016","article-title":"Structure of HIV-1 reverse transcriptase with the inhibitor beta-thujaplicinol bound at the RNase H active site","volume":"17","author":"Himmel","year":"2009","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2017.09.054_bib15","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1021\/acs.jmedchem.6b00465","article-title":"Design, synthesis, and biological evaluations of hydroxypyridonecarboxylic acids as inhibitors of HIV reverse transcriptase associated RNase H","volume":"59","author":"Kankanala","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.054_bib16","doi-asserted-by":"crossref","first-page":"6754","DOI":"10.1016\/j.bmcl.2010.08.135","article-title":"Potent and selective HIV-1 ribonuclease H inhibitors based on a 1-hydroxy-1,8-naphthyridin-2(1H)-one scaffold","volume":"20","author":"Williams","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.09.054_bib17","doi-asserted-by":"crossref","first-page":"16270","DOI":"10.1074\/jbc.M114.569707","article-title":"Inhibition of the ribonuclease H activity of HIV-1 reverse transcriptase by GSK5750 correlates with slow enzyme-inhibitor dissociation","volume":"289","author":"Beilhartz","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2017.09.054_bib18","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1021\/acs.jmedchem.5b01879","article-title":"3-Hydroxypyrimidine-2,4-diones as selective active site inhibitors of HIV reverse transcriptase-associated RNase H: design, synthesis, and biochemical evaluations","volume":"59","author":"Tang","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.054_bib19","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1021\/acs.jmedchem.6b00040","article-title":"3-Hydroxypyrimidine-2,4-dione-5-N-benzylcarboxamides potently inhibit HIV-1 integrase and RNase H","volume":"59","author":"Wu","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.054_bib20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejmech.2017.01.041","article-title":"6-Cyclohexylmethyl-3-hydroxypyrimidine-2,4-dione as an inhibitor scaffold of HIV reverse transcriptase: impacts of the 3-OH on inhibiting RNase H and polymerase","volume":"128","author":"Tang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.054_bib21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bmcl.2004.10.086","article-title":"The identification and optimization of a N-hydroxy urea series of flap endonuclease 1 inhibitors","volume":"15","author":"Tumey","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.09.054_bib22","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1021\/acs.jmedchem.5b01973","article-title":"Isoquinoline-1,3-diones as selective inhibitors of tyrosyl DNA phosphodiesterase II (TDP2)","volume":"59","author":"Kankanala","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.054_bib23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bmc.2011.10.058","article-title":"The design, synthesis and biological evaluations of C-6 or C-7 substituted 2-hydroxyisoquinoline-1,3-diones as inhibitors of hepatitis C virus","volume":"20","author":"Chen","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.054_bib24","doi-asserted-by":"crossref","first-page":"5590","DOI":"10.1016\/j.bmc.2007.05.029","article-title":"Selection, synthesis, and structure-activity relationship of tetrahydropyrido 4,3-dipyrimidine-2,4-diones as human GnRH receptor antagonists","volume":"15","author":"Lanier","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.054_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejmech.2009.09.025","article-title":"Substituted 2-aminothiopen-derivatives: a potential new class of GluR6-antagonists","volume":"45","author":"Briel","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.054_bib26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ejmech.2016.07.012","article-title":"Discovery of novel tetrahydrobenzo b thiophene and pyrrole based scaffolds as potent and selective CB2 receptor ligands: the structural elements controlling binding affinity, selectivity and functionality","volume":"122","author":"Osman","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.054_bib27","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3390\/v2040900","article-title":"HIV-1 ribonuclease H: structure, catalytic mechanism and inhibitors","volume":"2","author":"Beilhartz","year":"2010","journal-title":"Viruses-Basel"},{"key":"10.1016\/j.ejmech.2017.09.054_bib28","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/embor.2008.256","article-title":"Retroviral integrase superfamily: the structural perspective","volume":"10","author":"Nowotny","year":"2009","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ejmech.2017.09.054_bib29","doi-asserted-by":"crossref","first-page":"8765","DOI":"10.1021\/jm401232v","article-title":"Clicking 3 '-azidothymidine into novel potent inhibitors of human immunodeficiency virus","volume":"56","author":"Sirivolu","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.054_bib30","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1021\/cb600303y","article-title":"HIV-1 reverse transcriptase structure with RNase H inhibitor dihydroxy benzoyl naphthyl hydrazone bound at a novel site","volume":"1","author":"Himmel","year":"2006","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2017.09.054_bib31","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1021\/jm400645w","article-title":"Carbamoyl pyridone HIV-1 integrase inhibitors 3. a diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S\/GSK1349572) and (S\/GSK1265744)","volume":"56","author":"Johns","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.054_bib32","series-title":"Glide, Version 6.4","author":"Small-Molecule Drug Discovery Suite 2014-3","year":"2014"},{"key":"10.1016\/j.ejmech.2017.09.054_bib33","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.054_bib34","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1126\/science.282.5394.1669","article-title":"Structure of a covalently trapped catalytic complex of HIV-I reverse transcriptase: implications for drug resistance","volume":"282","author":"Huang","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2017.09.054_bib35","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/emboj\/20.6.1449","article-title":"Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA: DNA","volume":"20","author":"Sarafianos","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2017.09.054_bib36","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1093\/emboj\/cdf637","article-title":"Structures of HIV-1 reverse transcriptase with pre- and post-translocation AZTMP-terminated DNA","volume":"21","author":"Sarafianos","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2017.09.054_bib37","unstructured":"http:\/\/www.rcsb.org\/pdb\/explore\/explore.do?structureId=5J1E."},{"key":"10.1016\/j.ejmech.2017.09.054_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01351-17","article-title":"A\u00a02-hydroxyisoquinoline-1,3-dione active site RNase H inhibitor binds in multiple modes to HIV-1 reverse transcriptase","volume":"61","author":"Kirby","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2017.09.054_bib39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1006\/prep.1996.0004","article-title":"Single-step purification of recombinant wild-type and mutant HIV-1 reverse transcriptase","volume":"7","author":"Fletcher","year":"1996","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ejmech.2017.09.054_bib40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ab.2003.06.001","article-title":"A\u00a0fluorescence-based high-throughput screening assay for inhibitors of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H activity","volume":"322","author":"Parniak","year":"2003","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejmech.2017.09.054_bib41","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1021\/acs.jmedchem.7b00440","article-title":"Double-winged 3-hydroxypyrimidine-2,4-diones: potent and selective inhibition against HIV-1 RNase H with significant antiviral activity","volume":"60","author":"Vernekar","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.054_bib42","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1021\/jm070512p","article-title":"Rationally designed dual inhibitors of HIV reverse transcriptase and integrase","volume":"50","author":"Wang","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.054_bib43","doi-asserted-by":"crossref","first-page":"11952","DOI":"10.1128\/JVI.79.18.11952-11961.2005","article-title":"Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain","volume":"79","author":"Abram","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2017.09.054_bib44","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J.\u00a0Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2017.09.054_bib45","series-title":"Schr\u00f6dinger Suite 2014-3 Protein Preparation Wizard; Epik Version 2.9","author":"Schr\u00f6dinger Release 2014-3","year":"2014"},{"key":"10.1016\/j.ejmech.2017.09.054_bib46","doi-asserted-by":"crossref","first-page":"11225","DOI":"10.1021\/ja9621760","article-title":"Development and testing of the OPLS all- atom force field on conformational energetics and properties of organic liquids","volume":"118","author":"Jorgensen","year":"1996","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2017.09.054_bib47","series-title":"LigPrep, Version 3.1","author":"Schr\u00f6dinger Release 2014-3","year":"2014"},{"key":"10.1016\/j.ejmech.2017.09.054_bib48","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1128\/AAC.06000-11","article-title":"Structural and inhibition studies of the RNase H function of xenotropic murine leukemia virus-related virus reverse transcriptase","volume":"56","author":"Kirby","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2017.09.054_bib49","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.1093\/nar\/gkn464","article-title":"Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design","volume":"36","author":"Bauman","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2017.09.054_bib50","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1107\/S0907444913015308","article-title":"Decision making in xia2","volume":"69","author":"Winter","year":"2013","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2017.09.054_bib51","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"XDS","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2017.09.054_bib52","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0076-6879(85)14018-8","article-title":"Determination of protein molecular-weight, hydration, and packing from crystal density","volume":"114","author":"Matthews","year":"1985","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejmech.2017.09.054_bib53","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2017.09.054_bib54","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1107\/S0907444907037195","article-title":"MrBUMP: an automated pipeline for molecular replacement","volume":"64","author":"Keegan","year":"2008","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2017.09.054_bib55","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1021\/jm301271j","article-title":"Detecting allosteric sites of HIV-1 reverse transcriptase by X-ray crystallographic fragment screening","volume":"56","author":"Bauman","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.054_bib56","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1107\/S0907444906022116","article-title":"The Buccaneer software for automated model building. 1. Tracing protein chains","volume":"62","author":"Cowtan","year":"2006","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2017.09.054_bib57","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1107\/S090744490903947X","article-title":"Recent developments in classical density modification","volume":"66","author":"Cowtan","year":"2010","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2017.09.054_bib58","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2017.09.054_bib59","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2017.09.054_bib60","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1107\/S0907444998004119","article-title":"Incorporation of prior phase information strengthens maximum-likelihood structure refinement","volume":"54","author":"Pannu","year":"1998","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2017.09.054_bib61","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1107\/S0907444911001314","article-title":"REFMAC5 for the refinement of macromolecular crystal structures","volume":"67","author":"Murshudov","year":"2011","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2017.09.054_bib62","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417307699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417307699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:44:06Z","timestamp":1759326246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523417307699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":62,"alternative-id":["S0223523417307699"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.09.054","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluations of N-Hydroxy thienopyrimidine-2,4-diones as inhibitors of HIV reverse transcriptase-associated RNase H","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.09.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}